Sleep Medicine Reviews
Volume 4, Issue 3 , Pages 229-251 , June 2000

Efficacy and safety of herbal stimulants and sedatives in sleep disorders

  • Charlotte Gyllenhaal

      Affiliations

    • Program for Collaborative Research in the Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA
    • Institute for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston, IL 60201, USA
    • ,
  • Sharon L. Merritt

      Affiliations

    • Center for Nacolepsy Research, College of Nursing, University of Illinois at Chicago, 845 South Damen Avenue, Chicago, IL 60612, USA
    • ,
  • Sara Davia Peterson

      Affiliations

    • Program for Collaborative Research in the Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA
    • ,
  • Keith I. Block

      Affiliations

    • Program for Collaborative Research in the Pharmaceutical Sciences, College of Pharmacy, University of Illinois at Chicago, 833 South Wood Street, Chicago, IL 60612, USA
    • Institute for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston, IL 60201, USA
    • ,
  • Tom Gochenour

      Affiliations

    • Institute for Integrative Cancer Care, 1800 Sherman, Suite 515, Evanston, IL 60201, USA
    • College of Pharmacy, University of Illinois at Chicago, Chicago, IL 60612, USA

References 

  1. National Commission on Sleep Disorders Research . Wake Up America: A National Sleep Alert. Volume One, Executive Summary and Executive Report. Washington, D.C.: U.S. Government Printing Office. 1993;
  2. Bixler EO, Kales A, Slodatos CR. Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry. 1979;136:1257–1262
  3. Klink M, Qun SF. Prevalence of reported sleep disturbances in a general adult population and their relationship to obstructive airways diseases. Chest. 1987;91:540–546
  4. Mellinger GD, Balter MB, Uhlenhuth EH. Insomnia and its treatment. Arch Gen Psychiatry. 1985;42:225–232
  5. Ohayon M. Epidemiological study on insomnia in the general population. Sleep. 1996;19:S7–S15
  6. Johnson EO. 1998 Omnibus Sleep in America Poll.. Washington, DC: National Sleep Foundation. 199;
  7. Gallup Organization . Sleepiness in America. Washington, DC: National Sleep Foundation. 1997;
  8. National Center for Sleep Disorders Research and Office of Prevention Education and Control, National Heart, Lung and Blood Institute, National Institutes of Health . Working Group Report on Problem Sleepiness.. Washington, DC: Government Printing Office. 199;
  9. Carskadon MA, Dement WC. Normal human sleep: An overview. In Kryger MH, Roth T and Dement WC (eds). Principles and Practice of Sleep Medicine, 2nd ed. Philadelphia: WB Saunders. 1994;16–25
  10. Partinen M. Epidemiology of sleep disorders. In Kryger MH, Roth T and Dement WC (eds). Principles and Practice of Sleep Medicine, 2nd ed. Philadelphia: WB Saunders. 1994;437–452
  11. American Sleep Disorders Association . The International Classification of Sleep Disorders. (Revised). Rochester, MN: Author. 1997;
  12. Bassetti C, Aldrich MS. Narcolepsy. Neuro Clinics. 1996;14:545–571
  13. Kupfer DJ, Reynolds CF. Current concepts: management of insomnia. NEJM. 1997;336:341–346
  14. Goldbeck-Wood S, Dorozynski A, Lie L. Complementary medicine is booming worldwide. Br Med J. 1996;313:131–133
  15. Eisenberg DM, Davis RB, Ettner SL. Trends in alternative medicine use in the United States, 1990–1997. JAMA. 1998;280:1157–1569
  16. James JE. Understanding Caffeine: A Biobehavioral Analysis.. Thousand Oak, CA: Sage Publications. 1997;
  17. Grand AN, Bell LN. Caffeine content of fountain and private-label store brand carbonated beverages. J Amer Dietetic Assoc. 1997;97:179–182
  18. Tyler VE. The Honest Herbal: A Sensible Guide to the Use of Herbs and Related Remedies. 3rd ed. New York: Pharmaceutical Products Press. 1993;
  19. Smart Basics . Caffeine as an Effective Stimulant of the Central Nervous System. [On-line]. Available: www.smartbasic.com/glos/nutrients/caffeine.glos.html. 1997;
  20. Coffee Science Source. (n.d.) . Other Questions about Coffee and Health. [On-line]. Available: www.coffeescience.org/other.html. 1997;
  21. Herb Research Foundation . Herbal Stimulants. [On-line]. Available: www.herbs.org/greenpapers/stimulant.html. 1997;
  22. Snel J. Coffee and caffeine: Sleep and wakefulness. In Garattini S (ed). Caffeine, Coffee and Health. New York: Raven Press. 1993;229–255
  23. Pantelios G, Lack L, James J. Caffeine consumption and sleep. Sleep Research. 1989;18:65
  24. Smith AP, Maben A, Brockman P. The effects of caffeine and evening meals on sleep and performance, mood and cardiovascular functioning the following day. J Psychopharm. 1993;7:203–206
  25. Lack L, Miller W, Turner D. A survey of sleeping difficulties in an Australian population. Comm Health Stud. 1988;XII:200–207
  26. Karacan I, Thornby JL, Anch AM. Dose-related sleep disturbances induced by coffee and caffeine. Cl Pharmacol Therap. 1976;20:682–689
  27. Carsakadon MA, Dement WC, Mitler MM. Guidelines for the Multiple Sleep Latency Test (MSLT): a standard measure of sleepiness. Sleep. 1986;9:519–524
  28. Bonnet MH, Arand DL. Chronic caffeine effects on sleep, metabolism and daytime alertness. Sleep Research. 1991;20:211
  29. Lipschutz L, Berman S, Spielman AJ. Acute and chronic caffeine administration: alertness, cognition and diurnal variation. Sleep Research. 1990;19:74
  30. Zwyghuizen-Doorenbos A, Roehrs TA, Lipschutz L. Effects of caffeine on alertness. Psychopharmacology. 1990;100:36–39
  31. Walsh JK, Muehlbach MJ, Humm TM. Effect of caffeine on physiological sleep tendency and ability to sustain wakefulness at night. Psychopharmacology. 1990;101:271–273
  32. Penetar D, McCann U, Thorne D. Caffeine reversal of sleep deprivation effects on alertness and mood. Psychopharmacology. 1993;112:359–365
  33. Rosenthal L, Roehrs T, Zwyghuizen-Doorenbos BS. Alerting effects of caffeine after normal and restricted sleep. Neuropsychopharmacology. 1991;4:103–108
  34. Mitler MM, Walsleben J, Sangal RB. Sleep latency on maintenance of wakefulness test (MWT) for 530 patients with narcolepsy while free of psychoactive drugs. ElectroÍencephalography and Clinical Neurophysiology. 1998;107:33–38
  35. Mitler M, Aldrich MS, Koob GF. ASDA Standards of Practice. Narcolepsy and its treatment with stimulants. Sleep. 1994;17:352–371
  36. Anon . Dietary supplements containing ephedrine alkaloids. Federal Register. 1997;62:20677–30695
  37. Poceta JS, Hajdukovic R, Mitler MM. Improvement in cataplexy with yohimbine and paroxetine: case report. Sleep Research. 1994;23:304
  38. Sandler B, Aronson P. Yohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome. Urology. 1993;41:343–345
  39. Sonneborn U, Hansel R. Panax ginseng. In De Smet PAGM, Keller K, Hansel R, Chandler RF (eds). Adverse Effects of Herbal Drugs. Vol 2. Berlin: Springer-Verlag. 1992;179–192
  40. Avakian EV, Sugimoto RB, Tiguchi S. Effect of Panax ginseng on energy metabolism during exercise in rats. Planta Medica. 1984;50:151–154
  41. Liu CX, Xiao PG. Recent advances on ginseng research in China. J Ethnopharmacology. 1992;36:27–38
  42. Knapik JJ, Wright JE, Welch MJ. The influence of Panax ginseng on indices of substrate utilization during repeated, exhaustive exercise in man. Federation Proceedings. 1983;42:336
  43. Morris AC, Jacobs J, Kligerman TM. No ergogenic effect of ginseng extract ingestion. Medical Science of Sports Exercise. 1994;26:S6
  44. Forgo I. Effect of drugs on physical performance and hormone system of athletes. Munchener Medizinische Wochenschrift. 1983;125:822–824
  45. Forgo I, Schimert G. The duration of effect of the standardized ginseng extract in healthy competitive athletes. Notabene Med. 1985;15:636–640
  46. Pieralisi G, Ripari P, Vecchiet L. Effects of a standardized ginseng extract combined with demethylaminoethanol bitartrate, vitamins, minerals and trace elements on physical performance during exercise. Clinical Therapeutics. 1991;13:373–382
  47. Hallstrom C, Fulder S, Carruthers M. Effects of ginseng on the performance of nurses on night duty. Comparative Med East and West. 1982;6:277–282
  48. Wiklund I, Karlberg J, Lund B. A double-blind comparison of the effect on quality of life of a combination of vital substances including standardized ginseng G115 and placebo. Curr Ther Res. 1994;55:32–42
  49. Thomessen B, Laake K. No identifiable effect of ginseng (Gericomplex) as an adjuvant in the treatment of geriatric patients. Aging Clin Exp Res. 1996;8:417–420
  50. Siegel RK. Ginseng abuse syndrome—problems with the panacea. JAMA. 1979;241:1614–1615
  51. Balrrke MS, Morgan WP. Evaluation of the ergogenic properties of ginseng. Sports Med. 1994;18:229–248
  52. Bradley PM. British Herbal Compendium. Vol. 1. Bournemouth, UK: British Herbal Medicine Assoc. 1992;
  53. Asano K, Takahashi T, Miyashita M. Effect of Eleuthrococcus senticosus on human physical working capacity. Planta Medica. 1986;52:175–176
  54. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian ginseng. Can Med Assoc J. 1996;155:283–285
  55. Koren G, Rando S, Martin S. Maternal ginseng use associated with neonatal androgenisation. JAMA. 1990;264:2866
  56. Awang DVC. Siberian ginseng toxicity may be a case of mistaken identity. Can Med Assoc J. 1996;155:1237
  57. Sonneborn U, Hansel R. Eleutherococcus senticosus.. In: De Smet PAGM, Keller K, Hansel R, et al. (eds). Adverse Effects of Herbal Drugs. Vol. 2. Berlin: Springer-Verlag. 1993;159–169
  58. Findley L, Unverzagt M, Guchu R. Vigilance and automobile accidents in patients with sleep apnea or narcolepsy. Chest. 1995;108:619–624
  59. Braun R, Dittmar W, von der Hude W. Bacterial mutagenicity of the tranquilizing constituents of valerianaceae roots. Nauyn-Schmiedeberg's Arch Pharmacol. 1985;Suppl.329:R28
  60. Holz J, Godau P. Receptor binding studies with Valeriana officinalis on the benzodiazepine receptor. Planta Medica. 1989;55:642
  61. Santos M, Ferreira F, Cunha AT. An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Medica. 1994;60:278–279
  62. Garges HP, Varia I, Doraiswamy PM. Cardiac complications and delirium associated with valerian root withdrawal. JAMA. 1998;280:1566–1567
  63. Vorbach EV, Gortelmayer R, Bruning J. Therapie voninsomnien: wirksamkat und vertrliÍglichkeit eines Baldrian-preparates. Pharmakotherapie. 1966;3:109–115
  64. Schulz H, Stolz C, Muller J. The effect of valerian extract on sleep polygraphy in poor sleepers: a pilot study. Pharmacopsychiatry. 1994;27:147–151
  65. Leathwood PD, Chauffard F. Quantifying the effects of mild sedatives. J Psychiatr Res. 1983;17:115–122
  66. Balderer G, Borbely AA. Effect of valerian on human sleep. Psychopharmacol. 1985;87:406–409
  67. Gerhard U, Linnenbrink N, Georghiadou C. Effects of two plant-based sleep remedies on vigilance. Schweiz Rundsch Med Prax. 1996;85:473–481
  68. Schmitz J, Jackel M. Vergleichsstudie zur Untersuchung der lebensqualitat von Patienten mit exogenen Schlafstorungen (vorubergehenden Ein- un Durchschlafstorungen) unter Therapie mit einem Hopfen–Baldrian–Praparat und einem Benzodiazepin–Praparat. Wien Med Wochenschr. 1998;148:291–298
  69. Blumenthal M. The Commission E Monographs.. Austin TX: American Botanical Council. 1998;
  70. Medina JH, Viola H, Wolfman C. Neuroactive flavonoids: new ligands for the benzoÍdiazepine receptors. Phytomedicine. 1998;5:235–243
  71. Abdul-Ghani AS, El-Lati SG, Sacaan AI. Anticonvulsant effects of some Arab medicinal plants. Int J Crude Drug Research. 1987;25:39–43
  72. Avallone R, Zanoli P, Corsi L. Benzodiazepine-like compounds and GABA in flower heads of Matricaria chamomilla. Phytotherapy Research. 1996;10:177–179
  73. Gould L, Reddy CVR, Comprecht RF. Cardiac effect of chamomile tea. J Clin Pharmacol. 1973;13:475–479
  74. Hausen BM. The sensitizing capacity of Compositae plants. III. Test results and cross-reaction in Compositae-sensitive patients. Dermatologica. 1979;159:1–11
  75. Schultz V, Hansel R, Tyler VE. Rational Phototherapy.. Berlin: Springer. 1998;
  76. Shulgin AT. The narcotic pepper—the chemistry and pharmacology of Piper methysticum and related species. Bulletin of Narcotics. 1973;25:59–74
  77. Jussofie A, Schmiz A, Miemke C. Kavapyrone enriched extract from Piper methysticum as a modulator of the GABA binding site in different regions of rat brain. Psychopharmacology. 1994;116:469–474
  78. Lehmann E, Kinzler E, Friedemann J. Efficacy of a special kava extract (Piper methysticum) in patients with states of anxiety, tension and excitedness of non-mental origin—a double-blind placebo-controlled study of four weeks treatment. Phytomedicine. 1996;3:113–119
  79. Volz HP, Kieser M. Kava–kava extract WS 1490 versus placebo in anxiety disorders—a randomized placebo-controlled 25-week outpatient trial. Pharmacopsychiatry. 1997;30:1–5
  80. Woelk H, Kapoula O, Lehrl S. Behandlung von angst-patienten. Zeitschrift für Allgemeinmedizin. 1993;69:271–277
  81. Warnecke G. Psychosomatic disorders in the female climacterium, clinical efficacy and tolerance of kava extract WS 1490. Fortschritte der Medizin. 1991;109:119–122
  82. Emser W, Bartylla K. Improvement of sleep quality. Neurologie/Psychiatrie. 1991;5:636–642
  83. Klimke A. Has D, L-Kavain sleep-inducing properties?. Pharmacopsychiatry. 1992;25:
  84. Heinze HJ. Pharmacopsychological effects of oxazepam and kava special-extract in a visual search paradigm assessed with event-related potentials. Pharmacopsychiatry. 1994;27:224–230
  85. Münte TF, Heinze HU, Matzke M. Effects of oxazepam and an extract of kava roots (Piper methysticum) on event-related potentials in a word recognition task. Neuropsychobiology. 1993;27:46–53
  86. Russel PN, Bakker D, Singh NN. The effects of kava on alerting and speed of access of information from long-term memory. Bulletin of the Psychonomic Society. 1987;25:236–237
  87. Herberg K. Driving ability after intake of kava special extract WX 1490, a double-blind, placebo-controlled study with volunteers. Zeitschrift für Allgemeinmedizin. 1991;13:842–846
  88. Herberg K. Influence of Kava Special Extract WS 1490 in combination with ethyl alcohol on safety-related performance parameters. Blutalkohol. 1993;30:1–17
  89. Herberg K. Alltagssicherheit unter kava–kava extrakt, bromazepam und deren kombination. Zeitschrift für Allgemeinmedizin. 1996;72:973–977
  90. Almeida JC, Grimley EW. Coma from the health food store: interaction between kava and alprazolam. Annals of Internal Medicine. 1996;125:940–941
  91. Webb G. Kava improperly implicated in semi-comatose patient using conventional drugs. Herbclips Austin, TX: American Botanical Council. 1997;
  92. Johnson D, Frauendorf A, Stecker K. Neurophysiologisches wirkprofil und verträglichkeit von kava-extrakt WS 1490, eine pilotstudie mit randomisierter auswertung. Neurologie/Psychiatrie. 1991;5:349–354
  93. Norton SA, Ruze P. Kava dermopathy. J Amer Acad Dermatol. 1994;31:89–97
  94. Jappe U, Franke I, Reinhold D. Sebotropic drug reaction resulting from kava–kava extract therapy: a new entity. J Amer Acad Dermatol. 1998;38:104–106
  95. Atanassova-Shopova S, Roussinov KS. On certain central neurotropic effects of lavender essential oil. Bull Inst Physiol. 1970;8:69–76
  96. Buchbauer G, Jirovetz L, Jager W. Aromatherapy: evidence for sedative effects of the essential oil of lavender after inhalation. Z Naturforsch. 1991;46c:1067–1072
  97. Schultz V, Hubner WD, Ploch M. Clinical trials with phyto-psychopharmacological agents. Phytomedicine. 1997;4:379–387
  98. Hardy M, Kirk-Smith MD, Stretch DD. Replacement of drug treatment for insomnia by ambient odor. Lancet. 1995;346:701
  99. Diego MA, Jones NA, Field T. Aromatherapy positively affects mood, EEG patterns of alertness and math computations. Int J Neuro Sci. 1998;96:217–234
  100. Lindahl O, Lindwall L. Double-blind study of a valerian preparation. Pharmacol Biochem Behav. 1989;32:1065–1066
  101. Maluf E, Barros HMT, Forchtengarten MI. Assessment of the hypnotic/sedative effects and toxicity of Passiflora edulis aqueous extracts in rodents and humans. Phytother Res. 1991;5:262–266

PII: S1087-0792(99)90093-X

doi: 10.1053/smrv.1999.0093

Sleep Medicine Reviews
Volume 4, Issue 3 , Pages 229-251 , June 2000

Article Tools